TY  - JOUR
TI  - PHASE I CLINICAL STUDY OF A NEW RADIOPHARMACEUTICAL BASED ON RECOMBINANT TARGET MOLECULES DARPIN9_29 LABELED WITH 99mTECHNETIUM FOR RADIONUCLIDE DIAGNOSIS OF THE Her2/neu-POSITIVE BREAST CANCER
AU  - Bragina O.D.
AU  - Chernov V.I.
AU  - Larkina M.S.
AU  - Stasyuk E.S.
AU  - Zelchan R.V.
AU  - Medvedeva A.A.
AU  - Garbukov E.Yu.
AU  - Vernadskyi R.Yu.
AU  - Deev S.M.
AU  - Tolmachev V.M.
JO  - Molecular Medicine
PY  - 2021
IS  - 2
DO  - 10.29296/24999490-2021-02-06
UR  - https://new.molmedjournal.ru/en/24999490-2021-02-06
ER  -